BioCentury | Mar 31, 2021
Finance

March 31 Quick Takes: Muted reception for Achilles in market debut; plus BridgeBio-Helsinn, Scribe, Outpace, OnQuality, AffaMed, Treos

...2019. The financing included Shiyu Capital, Matrix Partners China, BioTrack Capital, CASH Capital, Sinovation Ventures, FreeS Fund...
BioCentury | Jun 25, 2019
Financial News

June 25 Financial Quick Takes: Tasly unit planning Hong Kong IPO; plus Vesalius, Mirati and more

...round led by Sherpa Venture Capital, with participation by China Growth Capital, Oriza Holdings and Frees Fund...
BioCentury | Jan 25, 2018
Financial News

XtalPi raises $15M series B

...$5 million in a series A round led by Tencent with participation by ZhenFund and FreeS Fund. Mary...
BioCentury | Dec 9, 2002
Tools & Techniques

States vs. drug prices

Squeezed between declining revenues and expanding numbers of poor and uninsured residents who need medical care, the states have become laboratories for experiments in drug cost containment. As a result they are developing policies that...
Items per page:
1 - 4 of 4
BioCentury | Mar 31, 2021
Finance

March 31 Quick Takes: Muted reception for Achilles in market debut; plus BridgeBio-Helsinn, Scribe, Outpace, OnQuality, AffaMed, Treos

...2019. The financing included Shiyu Capital, Matrix Partners China, BioTrack Capital, CASH Capital, Sinovation Ventures, FreeS Fund...
BioCentury | Jun 25, 2019
Financial News

June 25 Financial Quick Takes: Tasly unit planning Hong Kong IPO; plus Vesalius, Mirati and more

...round led by Sherpa Venture Capital, with participation by China Growth Capital, Oriza Holdings and Frees Fund...
BioCentury | Jan 25, 2018
Financial News

XtalPi raises $15M series B

...$5 million in a series A round led by Tencent with participation by ZhenFund and FreeS Fund. Mary...
BioCentury | Dec 9, 2002
Tools & Techniques

States vs. drug prices

Squeezed between declining revenues and expanding numbers of poor and uninsured residents who need medical care, the states have become laboratories for experiments in drug cost containment. As a result they are developing policies that...
Items per page:
1 - 4 of 4